We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
-15.41%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$62.7M
Cap. Flow
-$23.6M
Cap. Flow %
-9.27%
Top 10 Hldgs %
42.61%
Holding
95
New
26
Increased
21
Reduced
16
Closed
24

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$7.51M
2
BHC icon
Bausch Health
BHC
+$7M
3
MCK icon
McKesson
MCK
+$6.36M
4
AET
Aetna Inc
AET
+$5.78M
5
BIIB icon
Biogen
BIIB
+$4.95M

Top Sells

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$10.3M
2
CELG
Celgene Corp
CELG
+$7.45M
3
STJ
St Jude Medical
STJ
+$7.31M
4
ESPR
Esperion Therapeutics
ESPR
+$6.28M
5
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
+$4.15M

Sector Composition

Rank Sector Weight
1 Healthcare 74.13%
2 Financials 2.15%
3 Consumer Staples 1.24%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRMR icon
51
Larimar Therapeutics
LRMR
$444M
$1.28M 0.5%
+3,333
New +$1.5M
ALNY icon
52
Alnylam Pharmaceuticals
ALNY
$30.4B
$1.21M 0.47%
+15,000
New +$1.67M
ESPR
53
CALL
DELISTED
Esperion Therapeutics
ESPR
$1.18M 0.46%
50,000
+35,000
+233% +$2.2M
ESPR
54
DELISTED
Esperion Therapeutics
ESPR
$1.18M 0.46%
50,000
-100,000
-67% -$6.28M
GEN
55
DELISTED
Genesis Healthcare, Inc.
GEN
$1.1M 0.43%
180,000
+30,000
+20% +$203K
RXDX
56
DELISTED
Ignyta, Inc.
RXDX
$1.1M 0.43%
125,000
-25,000
-17% -$358K
AERI
57
DELISTED
Aerie Pharmaceuticals
AERI
$1.06M 0.42%
+60,015
New +$1.09M
ARIA
58
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.06M 0.42%
+125,000
New +$963K
OCUL icon
59
Ocular Therapeutix
OCUL
$2.22B
$1.05M 0.41%
+75,000
New +$1.51M
RVNC
60
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.04M 0.41%
+35,000
New +$1.06M
IMDZ
61
DELISTED
Immune Design Corp.
IMDZ
$915K 0.36%
75,000
-75,000
-50% -$1.41M
SUPN icon
62
CALL
Supernus Pharmaceuticals
SUPN
$2.74B
$912K 0.36%
+65,000
New +$1.21M
SCYX icon
63
SCYNEXIS
SCYX
$50.9M
$910K 0.36%
1,563
– –
ADAP
64
DELISTED
Adaptimmune Therapeutics
ADAP
$898K 0.35%
+75,000
New +$1.06M
DRNA
65
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$821K 0.32%
100,000
+25,000
+33% +$289K
ARWR icon
66
Arrowhead Research
ARWR
$12.1B
$720K 0.28%
+125,000
New +$786K
NVRO
67
CALL
DELISTED
NEVRO CORP.
NVRO
$696K 0.27%
+15,000
New +$727K
MRNS
68
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$626K 0.25%
+18,750
New +$1.06M
LITS
69
Lite Strategy Inc
LITS
$30.5M
$510K 0.2%
16,250
+3,750
+30% +$129K
CBAY
70
DELISTED
Cymabay Therapeutics
CBAY
$485K 0.19%
250,000
+10,000
+4% +$27.2K
CDMO
71
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$357K 0.14%
+50,000
New +$417K
ABT icon
72
CALL
Abbott
ABT
$193B
– –
-100,000
Closed -$4.91M
AFMD
73
DELISTED
Affimed
AFMD
– –
-10,000
Closed -$1.35M
AGIO icon
74
PUT
Agios Pharmaceuticals
AGIO
$2B
– –
-25,000
Closed -$2.78M
AVDL
75
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-25,000
Closed -$530K
1 2
3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2015 Portfolio in Review

As of Q3 2015, Iguana Healthcare Management held 95 positions worth $254M, down 20% from $317M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management withdrew a net $23.6M in Q3 2015, closing 24 positions and reducing 16 holdings. Its most notable exit was St Jude Medical, an estimated $7.31M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 68% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Iguana Healthcare Management opened a new position in McKesson worth $5.55M.

  • Iguana Healthcare Management's largest Q3 2015 buy was McKesson: 30,000 shares worth $5.55M.
  • Iguana Healthcare Management added most to Elevance Health in Q3 2015, an estimated $7.51M increase.
  • Iguana Healthcare Management's biggest Q3 2015 reduction was Ultragenyx Pharmaceutical, cutting an estimated $10.3M.
  • Iguana Healthcare Management fully exited St Jude Medical in Q3 2015, selling an estimated $7.31M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $254M portfolio in Q3 2015.
  • Iguana Healthcare Management opened 26 new positions and closed 24 in Q3 2015.
  • Iguana Healthcare Management's portfolio value fell 20% quarter-over-quarter to $254M.

Based on Iguana Healthcare Management's 13F filing for Q3 2015, filed 16 Nov 2015.